As per the latest report published by Persistence Market Research (PMR), the global intraoperative imaging market is set to a cross a valuation of US$ 513 million by the end of the forecast period (2016 -2024). PMR projects that the demand for intraoperative imaging will continue to gain traction owing to the robust adoption of minimally-invasive surgeries coupled with the impressive medical progress associated with diagnostic imaging for neurosurgeries. Many of prominent healthcare institutes are achieving groundbreaking success in developing new age imaging technologies.
By 2024-end, the global market for intraoperative imaging will increase at over 9.4% CAGR and is anticipated surpass US$ 1,145 Mn in terms of revenues. Growing popularity of Intraoperative imaging systems in the healthcare sector are encouraging industry leaders to upscale investments and go into strategic partnerships. However, lack of awareness of diagnostic benefits of intraoperative as compared to other alternatives amongst both patients and medical practitioners across the globe is likely to dampen the surging spirit of the market. Regularization of intraoperative imaging devices in diagnostic centers and hospitals worldwide is expected to further add on to features such as real-time imaging.
Browse Full Research Report:
https://www.persistencemarketresearch.com/market-research/intra-operative-imaging-market.asp
In terms of revenue, sales of intraoperative imaging systems account for more than 50 percent of the global market for intraoperative imaging. PMR indicates that throughout the projection period intraoperative imaging services will drop revenue share, reaching a market valuation of US$ 300 Mn by the end of 2024. In addition, use of intraoperative imaging is neurosurgery will continue to remain high throughout the projection period. On the basis of research findings, neurosurgical intervention will remain the predominant segment of the market. It is projected that globally neurosurgical imaging procedures will consume close to US$ 400 Mn worth intraoperative imaging systems by the end of forecast period. Further, cardiovascular and orthopedic diagnosis also represent as sizeable demand for intraoperative imaging solution.
PMR during the research identified that hospitals are the major end-users of intraoperative imaging systems. While hospitals will continue to maintain their dominance over 2024, cancer research institutes are also anticipated to their investment on intraoperative imaging systems. Using intraoperative imaging solutions, such institutes are aiming to enhance imaging and diagnostic methods for treating various types of cancers. Based on end-use, cancer research institutes segment accounted for closes US$ 180 million of the market globally in 2016.
Request and Download Sample Report@
https://www.persistencemarketresearch.com/samples/4517
On the basis of region, the market in North America is anticipated to remain dominant over the forecast period. Companies such as GE Healthcare, IMRIS Inc., Medtronic Plc. and NeuroLogica Corp are few of the prominent manufacturer of intraoperative imaging equipment headquartered in either Canada or the US. In the Europe, the market is likely to continue its steady growth in terms of revenue share. Meanwhile, the market in Asia-Pacific and Latin America will witness the highest growth, expanding at around 10% CAGR
Other major players operating in the global market for intraoperative imaging include Siemens AG, Toshiba Corporation, Koninklijke Philips NV, and Brainlab AG.
Comments
Post a Comment